Head And Neck Cancer

Mid-treatment imaging helped guide de-escalation of radiation for certain patients with oropharynx cancer, according to phase 2 study results presented at Multidisciplinary Head and Neck Cancers Symposium.

A blood test to detect circulating tumor DNA accurately predicted recurrence of HPV-driven oropharyngeal cancer after treatment, according to research presented at Multidisciplinary Head and Neck Cancers Symposium.

Oropharyngeal cancer incidence and mortality have increased steadily among men in the United States during the past 2 decades, according to study results published in JAMA Otolaryngology-Head & Neck Surgery.

Current treatments for thymic cancers did not significantly increase risk for cardiovascular disease, according to study results presented at American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology Patient.

In the final installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about which adults may derive the most benefit from catch-up HPV vaccination.

Survivors of head and neck cancer appeared at increased risk for a second primary lung cancer, according to results of an ad hoc secondary analysis of a randomized trial published in JAMA Otolaryngology-Head & Neck Surgery.

The William L. McGuire Lecture Award will be presented to Olufunmilayo Olopade, MD, FAACR, at San Antonio Breast Cancer Symposium this month.

Incidence of nasopharyngeal cancer differed greatly among Asian American ethnic subgroups, with significantly higher risk among Chinese and Laotian individuals compared with white individuals, according to study results.

Barbara Burtness, MD, understands that — in the medical profession — a culture of inclusion and diversity doesn’t just happen. It must be learned.

Treatment at high-volume radiation therapy facilities correlated with improved survival among select patients with common malignancies, according to study results published in Cancer.